6th Annual Pharma Pricing, Reimbursement & Market Access 2022 15th & 16th June 2022, Embassy Suites by Hilton Boston Logan Airport Boston, USA This conference will provide an overview of global pricing, market access systems and cost management techniques, as well as in-depth discussion of some of the most current trends and changes. This Conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. It will be studied with the help of case studies and industry experiences. Following a raft of health policy reforms impacting pharmaceutical pricing in almost every major country in the EU. DELEGATE REGISTRATION: Email - kavitha@virtueinsight.co.in or TEL: +44-20 3509 3779 STANDARD PRICE - 1 Delegates US $ 1599 For Group Discounts, Conference Sponsor, Exhibition Stall & Paid Speaker Slot - Please email your interest and queries to kavitha@virtueinsight.co.in KEY SPEAKERS: RICHARD LINER, Senior Assistant General Counsel, Bayer MARK MYERS, Director, Healthcare Resources Division, Office of Contract Review & Inspector General, United States Department of Veterans Affairs JOLIE APICELLA, Assistant, U.S. Attorney’s Office, EDNY RAHUL GOYAL, Senior Director, UnitedHealth Group GREG APOSTOL, Vice President and Head of Market Access, Alkermes MALLORY O’CONNOR, Executive Director, Public Policy, Mallinckrodt Pharmaceuticals BOXIONG TANG, Executive Director, HEOR, Global Medical Affairs, BeiGene MARTIN ROST, Senior Director, Market Access (Global), Pfizer KEREN TENENBAUM, Vice President of Legal & Compliance - U.S, Vifor Pharma MELVA COVINGTON, Senior Vice President, Research and Patient Outcomes, Curio Digital Therapeutics KEITH WHITE, Head, Global Market Access, Amylyx Pharmaceuticals STUART LEVINE, Partner, Chicago Pacific Founders HEATHER LEIGH FLANNERY, Founder & CEO, Equideum Health ROBERT POPOVIAN, Chief Science Policy Officer, Global Healthy Living Foundation AYESHA AZAM, Vice President of Medical Affairs, Patient Access Network (PAN) Foundation PETER BARSCHDORFF, Vice President, Deallus VIDYA BREEVELD–DWARKASING, Owner, Keen Access Insights (Former Head of Public Affairs & Market Access, Sanofi Pasteur) GARY ELLEXSON, VP Corporate Accounts, Supernus Pharmaceuticals MICHAEL THOMPSON, President & CEO, National Alliance of Healthcare Purchaser Coalitions ANDREW THORRENS, VP / Head of Market Access (US) and Reimbursement, ImprimisRx OMAR DABBOUS, VP, Global Health Economics & Outcomes Research & Real World Evidence, AveXis FANTA WATERMAN, Managing Director, Serrette Brown Research & Consulting EVERETT CROSLAND, Chief Commercial Officer, Cognito Therapeutics FABRIZIO GIANFRATE, Professor of Health Economics and Outcome Research - Market Access Independent Consultant - Ex Payer (Italy) KEY THEMES DISCUSSED: · Lessons learnt from the pandemic - Formulating your best market access strategy · Pharma pricing and market access in the US: concepts, components, and future · Prioritising Patients! - Adding value through an innovative patient-centred approach · Importance of working together: Stakeholders- Industry, Payers, Physicians and Patients · Improving patient and market access through the development of targeted value propositions, comprehensive contract assessment · Market access challenges facing the industry · Evidence Generation - The strategic rigor and creativity applied to evidence generation · How can payers and industry work together and importance for the same · Understanding - payers’ perspective · Advocating and collaborating with payers for value in a new era · How price affects market access and learn on how to set prices for optimal access & returns. · Developing risk-sharing reimbursement models and value-based pricing · Patient engagement and adherence within the environment · How to use the data sources and observational research for effective safety analysis · Dwell ahead of regulatory developments & improving your strategies in a cost-effective way · Be part of a major networking opportunity WHO SHOULD ATTEND: Senior Vice Presidents, Vice Presidents, Senior Executives, Global Heads, Heads, Directors, Senior Managers, Managers of: Pricing, Reimbursement, Market Access, Commercial Pricing, Pricing Strategists, Health Economics, Outcomes Research, Regulatory Affairs, Governmental Affairs, Public Affairs, Public Policy Directors, Operations, Governmental bodies, Regulatory bodies Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.

15th & 16th June 2022, Embassy Suites by Hilton Boston Logan Airport, Boston, USA We have been delivering the conference through close collaboration with the industry leaders for more than a decade. For the 2022 edition, the agenda includes a host of new and exciting features. Take a chance and make it count by attending this conference to network with your peers, exchange expertise and experiences, and arm yourself with the latest information to take your department to the next level. SPONSORS: SYNOWLEDGE, August Research DELEGATE REGISTRATION: Email - kavitha@virtueinsight.co.in or TEL: +44-20 3509 3779 Please note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer. Standard Pricing - 1 Delegate @ £1,599+20% VAT For Group Discount, Conference Sponsor, Exhibition Stall & Paid Speaker Slot - Please email your interest and queries to kavitha@virtueinsight.co.in KEY SPEAKERS: · MICHAEL FRIES, Head, Biostatistics, CSL Behring · JIM BUCHANAN, President, Covilance · BRIAN DREYFUS, Senior Director -Solid Tumor Oncology Epidemiology, Bristol-Myers Squibb · ELENA YURENEVA, Executive Director, Head of Medical Safety and Risk Management, Alnylam Pharmaceuticals · AJINKYA INAMDAR, Director, Global Medical Safety, Global Safety Strategy and Risk Management, Janssen Pharmaceuticals · NANCY DUBOIS, Head of Global Drug, Safety, United States Region, Merck-EMD Serono · SHARON REID, Director, Risk Management Product Lead, Pfizer · TEODORA DOHERTY, Global Medical Safety (GMS), Medical Safety Officer, Janssen Research & Development · FATIMA GHETHAN, Head of Quality and Medication Safety Department, King Abdullah Medical City (KAMC) – MAKKAH (Saudi Arabia) · HUMAIRA QURESHI, CEO, Synowledge · MOHAMMED BASEER AHMED, Executive Director, Drug Safety, Ionis Pharmaceuticals · TARAK THAKKER, Director, Safety Systems, BeiGene · NIRJHAR CHATTERJEE, Medical Director Pharmacovigilance, Medical Safety Rare Genetics and Hematology & PDT, Takeda · KATARINA ILIC, Senior Medical Director, Clinical Science, Rare, Genetics and Hematology TAU, Takeda Pharmaceuticals · KAL ELHOREGY, Director, Risk Evaluation and Mitigation Strategy (REMS) Programs, Amneal Pharmaceuticals · AYSE BAKER, Vice President of Regulatory Affairs, Almatica (Alvogen) · SUTAPA MUKHOPADHYAY, Director, Pharmacovigilance Operations, Deciphera Pharmaceuticals · MARCIN VON GROTTHUSS, Principal Scientist, Investigative Toxicology, Takeda Pharmaceuticals · HEMANG MAISURIA, Director, Global Safety Lead, Servier Pharmaceuticals · KAPIL BHUTADA, Director, Pharmacovigilance Compliance and Training, Medicago · BILL HADDOCK, Head of Safety, Ovid Therapeutics · NIBHA MISHRA, Senior Scientist, Investigative Toxicology, Takeda Pharmaceuticals · JERRY K. KOUNGA, Investigational Drug Lead Clinical Research Pharmacist, Ascension Wisconsin Research Institute · BEN LOCWIN, Executive SME, Black Diamond Networks · JESSICA VAUGHN, Attorney at Law, Wiley Rein · ELIZABETH WHITE BAKER, Associate Professor, Virginia Commonwealth University · LYNN MEHLER, Partner, Hogan Lovells WHO SHOULD ATTEND CEO’s, CTO’s, CIO’s, Presidents, VPs, Directors, Heads, Managers, Scientific Advisors, Consultants of: Pharmacovigilance, Pharmacoepidemiology, Pharmacogenomics, Drug/Product Safety, Drug Development, Information and Clinical, Data Management, Clinical Pharmacology, Clinical Safety, Periodical safety update Reports, Risk Management, Research & Development, Quality Assurance, Patient Safety, Signal Detection, Safety Surveillance, Outcomes Research, Data Analysis, Epidemiology, Medical Affairs, Regulatory Affairs and Compliance, Information technology, Sales and Marketing Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.